Facilitated By

San Antonio Medical Foundation

News

  • Puma Biotechnology Inc.: Puma Biotechnology Presents Interim Results of Phase II CONTROL ...

    ... (neratinib) were presented at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, ...

  • A look at how Texas is advancing in medicine and biotechnology

    The Texas business journals in Dallas, San Antonio, Houston and Austin are proud to bring you our inaugural edition of Innovations in Health Care, ...

  • Calithera Biosciences announces conference call to be held on December 12

    During the call, company will discuss recent CB-839 clinical data presentations made at the San Antonio Breast Cancer Symposium and the ...

  • Calithera Biosciences to Host Conference Call and Webcast to Review Data Presented at the San ...

    09, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage ... clinical data presentations at the San Antonio Breast Cancer Symposium, the ...

  • Avelas Presents Phase 1b Clinical Trial Data for AVB-620 at 2016 San Antonio Breast Cancer ...

    SAN DIEGO, CA, USA I December 8, 2016 I Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer ...